Research ArticleNEUROPHARMACOLOGY
3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
Jean De Vry, Dirk Denzer, Elke Reissmueller, Maud Eijckenboom, Markus Heil, Heinrich Meier and Frank Mauler
Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 620-632; DOI: https://doi.org/10.1124/jpet.103.062836
Jean De Vry
Dirk Denzer
Elke Reissmueller
Maud Eijckenboom
Markus Heil
Heinrich Meier
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 2
1 Aug 2004
Research ArticleNEUROPHARMACOLOGY
3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
Jean De Vry, Dirk Denzer, Elke Reissmueller, Maud Eijckenboom, Markus Heil, Heinrich Meier and Frank Mauler
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 620-632; DOI: https://doi.org/10.1124/jpet.103.062836
Research ArticleNEUROPHARMACOLOGY
3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
Jean De Vry, Dirk Denzer, Elke Reissmueller, Maud Eijckenboom, Markus Heil, Heinrich Meier and Frank Mauler
Journal of Pharmacology and Experimental Therapeutics August 1, 2004, 310 (2) 620-632; DOI: https://doi.org/10.1124/jpet.103.062836
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement